We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDHAW
1001
DELISTED
LDH Growth Corp I Warrant
LDHAW
$139K ﹤0.01%
185,000
-55,000
-23% -$55.9K
NSTD.WS
1002
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
$133K ﹤0.01%
149,444
-45,000
-23% -$50.9K
HERAW
1003
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$129K ﹤0.01%
125,000
LNZAW icon
1004
LanzaTech Global Warrant
LNZAW
$3.68M
$126K ﹤0.01%
+225,000
New +$119K
NSTC.WS
1005
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
$123K ﹤0.01%
124,036
-70,408
-36% -$82.6K
ANAC.WS
1006
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$111K ﹤0.01%
150,000
CLIM.WS
1007
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$110K ﹤0.01%
105,000
-70,000
-40% -$81.9K
NGC.WS
1008
DELISTED
Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share
NGC.WS
$104K ﹤0.01%
112,500
-56,250
-33% -$62.8K
FRSGW
1009
DELISTED
First Reserve Sustainable Growth Corp. Warrant
FRSGW
$89K ﹤0.01%
108,333
-108,333
-50% -$93.9K
FCAX.WS
1010
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$88K ﹤0.01%
100,000
FAZEW
1011
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$78K ﹤0.01%
100,772
-5,344
-5% -$5.12K
EMBKW
1012
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$77K ﹤0.01%
71,533
-79,166
-53% -$100K
ATAQ.WS
1013
DELISTED
Altimar Acquisition Corp III Warrants
ATAQ.WS
$70K ﹤0.01%
68,333
-88,333
-56% -$99.1K
MSACW
1014
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$62K ﹤0.01%
87,777
CAS.WS
1015
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$54K ﹤0.01%
86,525
ACET icon
1016
Adicet Bio
ACET
$85.6M
-30,500
Closed -$5.02M
AFRM icon
1017
Affirm
AFRM
$26.3B
-150,000
Closed -$10.1M
ALB icon
1018
Albemarle
ALB
$14B
-25,479
Closed -$4.29M
ALV icon
1019
Autoliv
ALV
$9.02B
-25,000
Closed -$2.44M
APG icon
1020
APi Group
APG
$18.1B
-18,715
Closed -$261K
ARDX icon
1021
Ardelyx
ARDX
$1.21B
-1,500,000
Closed -$11.4M
ARMK icon
1022
Aramark
ARMK
$15B
-254,430
Closed -$6.84M
BAH icon
1023
Booz Allen Hamilton
BAH
$8.65B
-30,232
Closed -$2.58M
BKKT icon
1024
Bakkt Inc
BKKT
$330M
-20,220
Closed -$5.06M
BLDR icon
1025
Builders FirstSource
BLDR
$8.16B
-400,000
Closed -$17.1M

Similar funds

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.